Mental health and behavioural conditions
Click on the links below to see details of all the clinical guidelines, published or in development, in this topic area.
Completed guidelines
Alcohol-use disorders: physical complications
Antenatal and postnatal mental health
Antisocial personality disorder
Anxiety
Attention deficit hyperactivity disorder (ADHD)
Bipolar disorder
Borderline personality disorder (BPD)
Dementia
Depression (replaced by CG90)
Depression in adults (update)
Depression in children and young people
Depression with a chronic physical health problem
Drug misuse: opioid detoxification
Drug misuse: psychosocial interventions
Eating disorders
Medicines adherence
Obsessive compulsive disorder (OCD) and body dismorphic disorder (BDD)
Post-traumatic stress disorder (PTSD)
Schizophrenia (replaced by CG82)
Schizophrenia (update)
Self-harm
Violence
When to suspect child maltreatment
Guidelines in development
Alcohol dependence and harmful alcohol use
Anxiety (partial update)
Autism spectrum disorders in children and young people
Autistic spectrum conditions in adults
Common mental health disorders
Conduct disorders in children and young people
Nocturnal enuresis in children (bedwetting)
Pregnancy and complex social factors
Psychosis with substance misuse
Self-harm (longer term management)
Click on the links below to see details of all the interventional procedures, published or in development, in this topic area.
Completed interventional procedures
Soft-palate implants for obstructive sleep apnoea
Soft-palate implants for simple snoring
Transcranial magnetic stimulation for severe depression
Vagus nerve stimulation for treatment-resistant depression
Interventional procedures in development
- None
Click on the links below to see details of all the Public health guidance, published or in development, in this topic area.
Completed public health guidance
Alcohol-use disorders - preventing harmful drinking
Behaviour change
Brief interventions and referral for smoking cessation
Interventions to reduce substance misuse among vulnerable young people
Mental wellbeing and older people
Needle and syringe programmes
Preventing the uptake of smoking by children and young people
Quitting smoking in pregnancy and following childbirth
School-based interventions on alcohol
School-based interventions to prevent smoking
Smoking cessation services
Social and emotional wellbeing in primary education
Social and emotional wellbeing in secondary education
Workplace interventions to promote smoking cessation
Public health guidance in development
Looked after children
Personal, social, health and economic education focusing on sex and relationships and alcohol education
Preventing domestic violence
Social and emotional wellbeing - vulnerable children at home
Social and emotional wellbeing: early education and childcare
Tobacco - nicotine replacement products sold by retailers
Tobacco - smoking cessation services for people using smokeless tobacco
Click on the links below to see details of all the technology appraisals, published or in development, in this topic area.
Completed appraisals
Alzheimer's disease - donepezil, galantamine, rivastigmine (review) and memantine
Attention deficit hyperactivity disorder (ADHD) - methylphenidate, atomoxetine and dexamfetamine (review)
Conduct disorder in children - parent-training/education programmes
Depression and anxiety - computerised cognitive behavioural therapy (CCBT)
Drug misuse - methadone and buprenorphine
Drug misuse - naltrexone
Electroconvulsive therapy (ECT)
Insomnia - newer hypnotic drugs
Schizophrenia - atypical antipsychotics (replaced by CG82)
Sleep apnoea - continuous positive airway pressure (CPAP)
Smoking cessation - varenicline
Structural neuroimaging in first-episode psychosis
Appraisals in development
Alzheimer's disease - donepezil, galantamine, rivastigmine and memantine (review)
Bipolar disorder (children) - aripiprazole
Dementia (non-Alzheimer) - new pharmaceutical treatments (suspended)
Schizophrenia - aripiprazole